New pain block cocktail could ease surgery recovery
NCT ID NCT07285083
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding dexmedetomidine to the standard painkiller bupivacaine in a nerve block (TAP block) provides better pain relief after abdominal surgery. 80 adults will be randomly assigned to receive either the combo or bupivacaine alone. Pain levels, sedation, and side effects will be tracked for 12 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine with dexmedetomidine
- What this could lead to
- If it works, this could provide better pain control after abdominal surgery with fewer side effects and less need for extra painkillers.
- What could go wrong
- This is a small, early-stage study (80 people) comparing two pain-block methods. The added drug may not improve pain relief or could cause more sedation or side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sheikh Zayed Medical College
RECRUITINGRahim Yar Khan, Punjab Province, 64200, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single nerve block slash opioid use in Children's elbow surgery?
- Can a simple pill speed up knee replacement recovery?
- A pinprick test may forecast severe pain after C-Section
- Smartphone video may read pain in a Patient's face
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Could a VR headset replace pills for surgery anxiety?